Impact of Adjuvant Chemotherapy After Chemoradiotherapy on Survival in Patients With Locally Advanced Cervical Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Adjuvant chemotherapy following chemoradiotherapy as primary treatment for locally advanced cervical cancer versus chemoradiotherapy alone (OUTBACK): an international, open-label, randomised, phase 3 trial
Lancet Oncol 2023 Apr 17;[EPub Ahead of Print], LR Mileshkin, KN Moore, EH Barnes, V Gebski, K Narayan, MT King, N Bradshaw, YC Lee, K Diamante, AW Fyles, W Small, DK Gaffney, P Khaw, S Brooks, JS Thompson, WK Huh, CA Mathews, M Buck, A Suder, TE Lad, IJ Barani, CH Holschneider, S Van Dyk, M Quinn, D Rischin, BJ Monk, MR StocklerFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.